Bharat Biotech's intra nasal vaccine iNCOVACC (BBV154), has received approval under Restricted Use in Emergency Situation for ages…
In controlled clinical trials for the Covid vaccine BBV154 as a primary and as a heterologous booster, Bharat…
Inoculating entire populations with a intra nasal vaccine would be faster in the thick of a covid19 viral…
Sign in to your account